Back to top

IMED Early Phase Drug Discovery Graduate Programme

Locations: Boston, US; Cambridge, UK; or Gothenburg, Sweden
Salary: Competitive and relocation support (where required)

Early Phase Drug Discovery Programme – applications are now open:

US: Closing Date is 20th January & Boston (Waltham) Assessment Centres will be on 19th & 20th March 2019

UK: Closing Date is 27th January & Cambridge Assessment Centres will be on 3rd & 4th April 2019

Sweden: Closing Date is 24th February & Gothenburg Assessment Centres will be on 24th & 25th of April 2019

Apply for IMED UK - closing date is 27th January 2019

Apply for IMED Sweden - closing date is Sun 24th February 2019

Apply for IMED US - closing date is 20th January 2019

About IMED

For IMED, collaboration is a way of life. We are committed to developing great science in our own labs, and combining this with the very best external science.

Each year we invest in excess of $1bn on discovering and developing the next generation of life changing medicines, from initial target selection through to the end of Phase two trials, and we're focused on driving the scientific advances in small molecules, RNA and other emerging technologies and drug discovery platforms to push the boundaries of medical science.

Find out more here.

 

Programme details

About the programme

The AstraZeneca graduate programme in Innovative Medicines and Early Development (IMED) is designed for those with a passion for science, and a desire to make a genuine difference to the lives of patients today and in the future. During the course of the programme, you will have the opportunity to make a real contribution to our projects and could find yourself involved in scientific breakthroughs that will help deliver the next generation of life saving medicines.

Our graduates undertake a two year programme where they will complete three different eight month placements across IMED with a focus on breadth of experience. All three placements will be completed at the strategic R&D site you join; in the US (Boston, Massachusetts), Sweden (Gothenburg); and the UK (Cambridge).

With a placement in the IMED Biotech Unit, you'll help translate the scientific advances we're making into the next generation of life-saving medicines. These are real projects with real responsibility. You could even be involved in our next scientific breakthrough.

What you can expect

We're looking for talented science graduates from a broad range of science disciplines with a bachelors or masters degree, who have graduated in 2018, or are due to graduate in 2019. We are particularly looking for those individuals who have a passion for science and really want to make a difference to patients worldwide by helping us to push the boundaries of science and develop the next generation of medicines that will revolutionise healthcare around the world.  

  • This is a two year programme and includes three individual eight-month placements through different areas of Innovative Medicines and Early Development, providing a broad exposure to multiple areas of basic and applied scientific research.
  • You'll be encouraged to make a real contribution to our projects from day one. So you'll find yourself involved in the design and development of new products leading to the next generation of life-saving medicines, right from the start of your career.
  • Graduates are enrolled in our Global Graduate Development Programme where we focus on the softer skills that are required to make the successful transition into industry. You will complete three modules where you will travel to one of our Global R&D sites to complete the programme and build your knowledge of the exciting science and facilities that are located on each of our R&D sites. Graduates are also aligned to a mentor who is a senior leader in the organisation and will support you for the duration of the programme.
  • You can also expect a competitive salary and benefits.
  • We offer all graduates a generous relocation support if required including Swedish language lessons if you are moving to Sweden.

What does the programme involve?

The IMED Early Discovery Science Graduate Programme will give you broad experience of the drug discovery process by immersing you in real science, giving you responsibility on real projects from the outset and providing ongoing mentoring. The programme includes three rotations, which you can choose from an extensive range of placements, allowing you to tailor your development to your particular passion. We'll also help you to develop soft skills to ease your transition into industry.

Wherever you're based, you'll be working with colleagues who are true experts, as well as with academic institutions and like-minded scientific companies. All in all, the programme provides a springboard to great things, within or outside AstraZeneca. 

Essential requirements

What we're looking for:

  • Science graduates with a minimum of a 2:1 or local equivalent Bachelor's degree or Masters gained in 2017 or 2018
  • Bright, motivated and highly driven individuals with a real passion for drug development 
  • Innovative thinkers with enthusiasm and energy to match their scientific expertise
  • Ability to work as part of a collaborative team that focuses unequivocally on patient needs
  • Strong critical thinking, stakeholder management, planning, organisational and time management skills

Now is a great time to be a scientist in AstraZeneca. Working across a range of therapy areas our IMED teams are focussed on translating the really cool science that is happening in our labs into the next generation of medicines that patients need.

To make this happen we need great people who share our passion for science and who have the drive and determination to meet the unmet needs of patients around the world.

Therefore our graduates have a range of opportunities to meet with scientists and at every level of our organisation are actively encouraged to go out and speak to our leaders and scientists to obtain more information of the great science that we do.

Mene Pangalos EVP, IMED Biotech Unit

Meet our people

Victorine Muse

Victorine Muse

My name is Victorine and I studied Biological Engineering for my undergrad at Cornell University where I remained to earn my master’s degree in Biomedical Engineering.

While at Cornell, I spent five years in a biomedical engineering lab studying brain blood flow mechanics in Alzheimer’s disease using transgenic mouse models. While I enjoyed the research, I didn’t feel that academic research was the right course for me and decided to pursue opportunities within industry. I had heard that several biotech companies offered rotational programs that allowed recent graduates to explore different areas of their company before settling on a career path. This sounded ideal for me as I was not sure what opportunities within industry would best suit my skills and interests. With some research, I came across the program at AstraZeneca, which ended up being a perfect fit!

My first placement was in Modelling and Simulation within Drug, Safety, and Metabolism (DSM). I chose this placement because I was briefly exposed to computational work in my lab at Cornell and I loved it. This rotation gave me an opportunity to expand my skills and learn new computing languages, a goal of mine upon entering the program. My project focused on modelling the pharmacokinetic and pharmacodynamics (PKPD) of drugs on a new microphysiological system (MPS) from a company AstraZeneca has been collaborating with. The device was developed to detect cardiotoxicity at the in vitro level to reduce and potentially remove the need for in vivo cardiotoxicity studies during future clinical development. The work was very enlightening as it taught me about both the rewards and hardships with working with outside collaborators. In the end, my work on the project was even published!

For my current rotation I wanted to further expand my computational skills so I joined the bioinformatics team. This work has helped me develop as a scientist. I have been able to immerse myself in cancer genetics, which I have always found interesting but never had the chance to learn about until now. My current project has me exploring a pilot study for AML which has been really exciting, especially as I have a lot of control over where the project goes.

As I look towards my last rotation, I have been trying to figure out my career plan beyond the Graduate Programme. While I am certain I want to pursue a future in computational work within industry, I am not sure if I want to pursue a PhD first. My mentors at AstraZeneca have been amazing and have offered me valuable advice and introduced me to people who can help me figure out what’s best for my future. Overall the programme was critical in advancing my career and I definitely wouldn’t have discovered my current passion for computational work without it.

Ted Bebi

Ted Bebi

My name is Ted and I am originally from Albania. For the past 5 years I have been living in the United States where I completed my undergraduate degree at Macalester College studying biology and statistics. After graduating I was enthusiastic to join the AstraZeneca IMED Graduate Programme in Boston.

Throughout my college career I worked in multiple academic labs which sparked my interest in biological sciences. However, I was curious about the way industry approaches the scientific process of drug discovery. By allowing you to rotate between three different placements, the IMED Graduate Programme offers you the opportunity to explore your interests while also developing knowledge and skills across different fields of drug discovery.

During my first placement I worked in an immuno-oncology project focusing on how a specific cancer drug impacted the immune system. I became familiar with the kind of work and experiments that are necessary to bring a drug to the clinic. It also allowed me to develop skills such as western blotting, cell viability assays, flow cytometry and becoming comfortable in presenting data in group meetings. For my second placement, I decided to do something completely different and join the Bioinformatics team. This has been a great experience as my understanding of biology has expanded in a novel way and I am developing a new skillset by learning how to code and using different software.

In addition to the work related to my placement, I have enjoyed taking on co-leadership of ‘AZ Early Talent’, which is the company’s organization for employees at the start of their scientific careers. Through the organization we have been able to organize talks, volunteering events, and art contests, and engage more with the people we work with. It has allowed me to take on more creative responsibilities while getting to know the company and industry better.

The Programme has been great as I have learned a lot and met very intelligent and inspiring people. I have discovered I really enjoy Bioinformatics work and I am now able to make more informed decisions about my career. I am excited about what the next year will bring and gaining even more experience in the field.

Julia Weigandt

Julia Weigandt

My name is Julia and I graduated in Biological Chemistry and Drug Discovery from the University of Dundee in 2017. During my degree I developed a great interest in medical research and drug development, and I knew I wanted to work in an area where science directly translates into the benefit of patients.

I successfully applied for AstraZeneca’s Undergraduate Industrial Placement Scheme (UIPS), and joined the Structure and Biophysics Team. This allowed me to gain an insight into the early stages of drug discovery, as well as a feel for how AstraZeneca is investing in ground-breaking research. I also gained a better understanding of the pharmaceutical industry. During my placement I learned about the IMED Graduate Programme and it became the clear choice for me after completing my studies.

My first rotation was based in Structure and Biophysics. My previous experience allowed me to expand my understanding of target-ligand interactions and enhance my skills in biophysical applications such as Surface Plasmon Resonance and Differential Scanning Fluorimetry.

I was providing biophysical support for several active drug discovery projects at various progress stages - from hit discovery to lead optimisation. It was incredibly exciting to be involved in a fragment based lead generation project involving a “difficult-to-target” protein target. I was a member of a very enthusiastic team that brought together expertise from a variety of areas such as fragment chemistry, X-Ray crystallography, computational chemistry, protein science and biochemistry. It was a great learning experience!

I am currently on my second rotation based in the Advanced Drug Delivery within our Pharmaceutical Sciences function. The increased focus on exciting new modalities such as siRNA, therapeutic peptides and antibodies has created an urgent need for novel delivery strategies for such medicines. It is truly exciting being part of a new group within AZ whose aim it is to establish an in-house expertise in nanomedicine and nanotechnology for a game changing translation of our therapeutics.

My project is focusing on obtaining a fundamental understanding of cellular interactions and cellular uptake of nano drug carriers depending on their surface properties. This could enable us to develop a strategy to target immune cells more effectively.

Overall, the IMED Graduate Programme has enabled me to explore my personal interests and gain competence across many scientific areas – some outside of my comfort zone! The programme also highlights personal development, and has helped me develop my leadership skills through the ‘Graduate Development Programme’. Each module takes place in a different location, allowing us to visit AZ sites in Sweden and the US, and to engage with members of the AstraZeneca leadership team across science and business.  I recommend the IMED Graduate Programme to any open-minded science graduate who is interested in exploring the field before striving for a PhD, as well as those looking to start their career in the pharmaceutical industry.

All in all, I am looking forward to one more year with AZ!

Mehul Jesani

Mehul Jesani

My name is Mehul and I am currently on my second rotation as part of the Innovative Medicines and Early Development (IMED) Graduate Programme in the UK. Before joining AstraZeneca, I graduated from the University of Cambridge with an integrated Master’s degree in Natural Sciences, specialising in Chemistry. AstraZeneca has a growing footprint in Cambridge, and I had the opportunity to meet some IMED Graduates at a careers event in Cambridge while I was studying. I chose to apply for the IMED Graduate Programme to build on the skills I learned at university, and apply them in a cutting-edge research environment for the benefit of patients. I also wanted to make a more informed decision about whether to pursue a PhD, or a career in industry.

My first rotation was in Oncology Chemistry, where I worked as a synthetic and medicinal chemist on a drug discovery project, and progressed sets of potential drug molecules through the cycle of Design-Make-Test-Analyse to identify a new candidate drug. I could directly apply and build on my synthetic chemistry experience from university to make compounds for the project, and this really helped me find my feet during my first few months at AstraZeneca.

My project team was made up of experienced scientists from a range of disciplines who met on a weekly basis. I really enjoyed seeing how the biological assay data for my compounds informed future compound designs, and having the opportunity to regularly present the results of my experiments to the team. This is how my ability as a medicinal chemist quickly grew, and I became more confident at presenting my work – something I had identified as an area I wanted to improve through discussions with my mentor (a senior leader in the company) and buddy (an IMED Graduate from previous year’s intake). A major highlight of my first rotation was developing my presentation skills through participation in the National Retrosynthesis competition. I joined a team of AstraZeneca chemists and presented our proposed synthesis of a complex natural product in front of teams from across academia and industry, and a panel of expert judges that awarded us third place overall.

The IMED Graduate Programme is unique in offering the prospect to challenge yourself by selecting rotations to work in branches of science that are completely new to you. This is something I would encourage, because plenty of support is available to bring you up to speed, reducing any barriers to exploring diverse areas within IMED. Because of this, I chose to stretch myself by undertaking my second rotation in a very different area: Structure, Biophysics and Fragment Based Lead Generation, a part of Discovery Sciences. So far, this has involved investigating how compounds bind to target proteins through biophysical techniques, such as surface plasmon resonance and differential scanning fluorimetry, which I had no prior experience of. However, I was quickly trained with the different instruments, and now support two fragment based lead generation campaigns that are looking to explore exciting new treatments that work by degrading disease target proteins, instead of simply inhibiting them.

I have found that there is a big focus on development within the IMED Graduate Programme and across AstraZeneca. Project teams are receptive to Graduate Scientists guiding the direction of their rotations to fit their interests: over the second half of my current rotation, I am looking to learn more about the fragment based lead generation approach and understand how the biophysical data I collect contributes to drug discovery projects. As well as building your skills as a scientist, the IMED Graduate Programme puts a strong emphasis on your personal and professional skills, especially through the Global Graduate Development Programme. Each of the three modules help develop a range of valuable, transferable skills that make you more effective in your job, and also provide you with a strong foundation for your future career, whether it’s in academia or industry.

Lavaniya Kunalingam

Lavaniya Kunalingam

My name is Lavaniya, I joined the Innovative Medicines and Early Development (IMED) Graduate Program in Gothenburg in September 2017 and I am currently on my second placement. I am a graduate from an Engineering school in France with two Masters in Science (one in Chemical Engineering and the other in Organic, Bio-inorganic and Therapeutic Chemistry).

I am a chemist by training but I’ve always been interested in working at the interface of chemistry and biology. More specifically, I aspire to be a chemical biologist studying the field of oncology. The IMED graduate program appealed to me as the perfect opportunity to fulfil my scientific curiosity, by letting me develop as a scientist and gain a deeper insight into the different fields I am passionate about.

This program is allowing me to acquire a broad experience starting from organic/peptide synthesis to cell and molecular biology. I completed my first placement in the oncology field within the Discovery Science department. I worked in a multidisciplinary team, exploring the application of extracellular vesicles (EVs) in the delivery of siRNA targeting KRASG12D in pancreatic cancer. I had the opportunity to become familiar with a range of cellular and molecular biology techniques as well as discover exosomes-based therapy which is an emerging field in oncology. Throughout the placement, I was supervised and trained technically and theoretically by experts in the field. I was also exposed to work closely and present my work to many departments within AstraZeneca, both locally at team meetings and across sites in global project meetings (Oncology in Boston and Cambridge, Pharmaceutical Sciences in Gothenburg, etc…).

After my first placement in biology, I wanted to strengthen my experience as a chemist. I am currently on my second rotation in another innovative and emerging field of drug development: New Modalities (peptides and oligonucleotides based drug) in the Respiratory, Inflammation and Autoimmunity department, where I work on the synthesis of stapled Bicycle® peptides for inhibition of cytokine receptor interaction.

The graduate program does not just allow young scientists to work on exciting, live projects at AstraZeneca, but it also helps us to develop our so-called soft skills with three, different, Global Development Modules where all Graduates across the sites meet in Gothenburg, Cambridge and Boston. Those modules are led by professional coaches and help the Graduates to consolidate many professional skills. Furthermore, during this two-year program, a Team Leader/Principal Scientist is assigned to each of us as a mentor to give us advice and guide us on our career to become better scientists. 

During this program, I am gaining extensive knowledge, a broad scientific network, diverse experimental skills and a deep insight into chemistry and biology. In my opinion, it’s the perfect opportunity for a young scientist to learn and train in a world-renowned pharmaceutical company where the science is great and the atmosphere is supportive.

Stefan Moravcik

Stefan Moravcik

My name is Štefan and I come from Bratislava, Slovakia. I studied at Pharmaceutical faculty in Hradec Králové, Charles University. I knew that I would like to do science after university, so when I found out about AstraZeneca’s IMED Graduate Programme in Gothenburg, Sweden I was immediately interested.

My aim was to gain valuable laboratory experience before choosing an area to specialise in for my PhD. The ability to choose three placements across a variety of departments, and learn a wide range of skills and techniques, was exactly what I was looking for.

During my first rotation, I spent 8 months within the Rapid Route Design Team, where I worked on synthetic route optimisation. I had the opportunity to work on two different projects, which were both really important for the company. It was very motivating and rewarding to see that the work I delivered had a real impact. I also had the opportunity to present my results in the form of a poster at an internal AstraZeneca conference, which was a great opportunity to connect with other scientists from our Cambridge (UK) and Boston (US) sites.

I have recently moved into my second rotation in the New Modalities Team of the Cardiovascular, Renal and Metabolic Diseases Unit (CVRM). Specifically, I aim to develop methodologies that utilize simple building blocks that can be diversified via novel activation modes of traditionally inert C–O bonds using cutting edge photoredox and transitional metal catalysis.

My colleagues have been very helpful on both my rotations, and their supervision has been invaluable. When I look back I see that I have learned a lot of skills which will prepare me for my future career in industry as a chemist. At the same time, the working environment at AstraZeneca is amazing, and it is a really fulfilling and satisfying place to work.

Besides science, we have three Developmental Modules whilst we’re on the IMED Graduate Programme. These modules are focused on developing soft-skills which are really important for day-to-day life.  Each module takes place at a different site, so besides Gothenburg, I get to explore Cambridge and Boston.

Since joining the IMED Graduate Programme, I recommend it to all of my friends who are interested in science. It is an excellent opportunity to learn, and the perfect step into a PhD.  

Frequently asked questions

About the programme

About the programme

How will the programme work?

You would join AZ on a two year fixed term contract and will complete three placements of eight months each across different parts of Innovative Medicines and Early Development. We want to focus on ensuring that you obtain breadth of experience at this stage and will provide as much exposure to as many different parts of Innovative Medicines and Early Development as possible.

Placements cover all the different areas of Innovative Medicines and Early Development and if you are a Chemist for example you might find that you have one placement in Global DMPK, followed by Medicinal Chemistry and Computational Chemistry.

There are many different placements available so our graduates follow many different pathways. Our Bio scientists for example might find themselves in placements in Translational Science, Precision Medicine & Genomics, and Drug Safety and Metabolism or Bioscience.

Will I have a choice of where my placement would be?

You would have regular discussions with your mentor, line managers and programme managers in order to establish your development needs and aspirations. All graduates on the programme are encouraged to reach out to potential placement line managers to discuss the placement and the science conducted within it.

All graduates then submit their preferences in terms of the placement team they would like to join, and this preference is the main driver of how we allocate graduate placements. We do not plan all 3 placements in advance as we feel it is important to allow our graduates to find out more about our business and their interests and development needs before deciding where they would like to be placed.

Graduates on the programme have the opportunity to express preferences of where they would like to be placed on their first rotation prior to joining us.  All of our graduates have been happy with their placements and the options open to them as we have a wide range of placements available so we really do have something for everyone what ever your scientific interests.

What kind of work will I be doing?

All of our graduates are fully immersed within our teams in the organisation and take on real roles and responsibilities from day one. Our graduates in Innovative Medicines and Early Development are working on a wide range of scientific advances in drug discovery from initial target selection through to the end of Phase 2 trials so whatever your passion and interest there will be an opportunity to work on important areas of drug discovery.

You never know - you could be working on the next scientific breakthrough. Some of the areas that our graduates are currently working in include: Translational Science, Precision Medicine & Genomics, Computational Chemistry, Drug Safety & Metabolism, Global DMPK, Structure and Biophysics and Early Clinical Development across the range of our therapy areas.

Some of our graduates have even had the opportunity to get involved in a scientific publication or presenting their work to a scientific conference, although this is not guaranteed as part of the programme.

How will my performance be managed?

Performance management is a continuous process at AstraZeneca. You should expect to have regular performance discussions with your placement manager and mentor. 

You may also be allocated a supervisor who will work with you and the line manager to ensure that you get all the support you need to succeed.

What opportunities will I have to present my work?

All of our graduates are required to produce a poster at the end of each placement which is then presented at a site based poster session. This provides our graduates with a great opportunity to present their work and talk about the science that they have been working on.

This is also a great opportunity for all graduates to find out more about the science conducted on each of the placements on the programme. Some of our graduates have also been selected to present their posters at our Internal Science Symposiums at our sites in other countries.

Will I obtain a permanent role at the end of the programme?

We are not able to guarantee you a permanent role at AstraZeneca at the end of the programme. You would have the opportunity to apply for a role in AstraZeneca at the end of the programme and a number of our graduates have been successful in obtaining a position with us.

Other graduates have moved onto an AZ Sponsored/Industrial PhD and will continue to work with us as they complete their research.  Other graduates move on to PhD programmes independent of AZ or employment in other organisations.

Whatever the outcome at the end of the programme for you we are confident that you will benefit significantly from the skills and experience that you would obtain from the completion of the IMED Graduate Programme. All of our graduates have said that they have benefited enormously from their time on our graduate programme which has served as the springboard to their next career step whether this be a PhD or employment.

Will I have an opportunity to work overseas as part of the programme?

We do not currently offer international placements as part of the IMED Early Phase Drug Discovery Programme.

Opportunities for development

Opportunities for development

What are the opportunities for development?

You will be encouraged to grow and develop throughout the 2 year programme. A number of development interventions will be put into place including drug discovery and development training as well as other relevant technical and specific placement training.

All graduates will also be enrolled into our global graduate development programme to supplement the on placement skills and experience.

What does the graduate development programme cover and how will it work?

We are working with an external partner to deliver our graduate development programme who specialises in graduate development. The development programme will focus on 3 core areas of being successful, being a great scientist and planning for the future.

Our graduates travel as a Global Cohort to each of our core R&D Sites to complete one of the modules so you will have the opportunity to travel to the UK, US and Sweden as part of the programme. We always take the opportunity to spend the whole week together to learn more about the particular site.

The development programme also provides an opportunity for our graduates to meet their global peers and to understand more about our business. Our graduates feel that the development programme really helps them to develop the softer skills that they need to succeed.

What else will be involved in the programme?

The development programme is very interactive and we use professional actors to help you to develop the communication skills and confidence that you need to succeed in AstraZeneca. The graduates also have the opportunity to work as teams on real business related projects and tasks.

We also encourage the graduates to make video diaries and complete a learning journal so that they can keep an accurate record on their development on the programme. The modules are also supplemented with pre and post workshop interventions including the use of a range of online tools and technologies.

All graduates on the programme will also form global learning network groups to support each other through the programme. Your line managers and mentors will also be trained to ensure that you gain the most benefit from this opportunity.

What other opportunities are there for development on the programme?

Graduates on the programme are encouraged to seek our opportunities to enrich their own personal development. We encourage AstraZeneca Graduates to apply for a place on the prestigious GAP Summit, and support them if they are successful. Others have had the opportunity to meet Nobel Prize winners and to attend internal symposiums and conferences.

A number of graduates have been shortlisted to present their work at the IMED Science Symposiums at another R&D Site.

The roles within the programme

The roles within the programme

What does the programme manager do?

The programme manager is the person is responsible for the delivery of the graduate programme for Innovative Medicines and Early Development. The programme manager manages the attraction, recruitment and onboarding of all graduates on the programme working in conjunction with regional programme team members and the Early Talent Coordinator.

The programme manager also works with all graduates to establish placement preferences and to ensure that we have the appropriate number and range of placements, mentors and line managers to deliver the programme.

The programme manager also works with our training company to design and deliver the Global Graduate Development programme.

What is the role of the mentor?

The mentor is a leader within the organisation who will support you for the duration of the programme by offering career guidance, advice and support. The mentor is also there to challenge your thinking and to provide a different perspective to that of the placement and programme manager.

Our current graduates really value this different perspective and having this 1:1 support for the duration of the programme.

Who will be my line manger?

You will have 3 different line managers during the course of the programme as you will have a different line manager for each of your placements. Your line manager may also involve a lab supervisor. Your line manager will work with you to identify your objectives for your placement and will also ensure that you have the relevant training and resources to be able to make a valuable contribution to our projects whilst you are working with them.

Your line manager will conduct your end of placement review ensuring that you will have an opportunity to summarise what you have achieved on your placement.

About our selection process

About our selection process

How many positions are you recruiting?

Globally we are looking to recruit approximately 20 new graduates in 2018 and 2019.

What countries are you recruiting in?

We will have IMED graduates based in our Strategic R&D Sites in Gothenberg in Sweden, Waltham, Massachusetts in the US and Cambridge in the UK.

What will the selection process look like?

We have developed a robust selection process that will enable us to ensure that we select the best candidates to join our programme. This will consist of a number of different types of exercises and interviews that will test your technical knowledge and interpersonal skills.

You will be provided with detailed information on how you can prepare for one of our selection events at one of our sites should you be shortlisted. Our assessment centres are very much a two way process and this is our opportunity to find out about your suitability for a place on our programme but it is also your opportunity to find out whether the programme is right for you.

Previous candidates have commented on how useful they have found our assessment centres to be in providing an insight into drug discovery even if they have been unsuccessful at obtaining a place on the programme.

Can I apply for a position in more than one county?

As the selection process is managed by a Global Team who manage all of our recruitment globally you do not need to do this. We request that you apply into one region only and state a willingness to work in the other regions as part of your application process.

When can I expect to hear whether my application has been successful?

We aim to contact all candidates within 4-6 weeks from the closing date to confirm whether you have been shortlisted to progress within our process. Please bear in mind that our advert will be open for a number of months and you will not hear anything from us with regards to the progress of your application during this time.

Will I be provided with feedback if my application has been unsuccessful?

Due to the volume of applications that we receive we regret that we are unable to provide feedback to these candidates who have not been shortlisted at our application stage. However all candidates who are progressed to interview will be provided with feedback if their application has been unsuccessful.

What if I cannot make the selection dates that you have indicated?

As we hold global events at a number of our key R&D sites we will be unable to offer an alternative date for candidates who cannot make the assessment dates. We therefore, include details of our assessment centre dates on our advertisements so candidates are clear about this when they submit their applications.

What is the salary and benefits package?

We offer a very competitive salary and benefits package including an annual performance bonus, flexible benefits and private healthcare.

Will I be provided with relocation support?

All graduates who join the programme are provided with relocation assistance if required.

Overseas graduates who are relocating to Sweden are also provided with language lessons and a settling in support where we will provide assistance with the establishment of national insurance numbers and bank accounts. All graduates who are moving into a new country will also be provided with relocation support from an external vendor to help you to find a place to stay.

I do not have any lab work experience - will that be a problem?

Whilst any work experience is very valuable for candidates this is not essential. Our programme is very much part of our longer term strategy so we look for candidates who have a real passion for science and who want to make a difference to the lives of patients and candidates should not be discouraged from applying if they feel they have the right skills and qualities to succeed on our programme.

What disciplines do you recruit?

We recruit a broad range of science disciplines on the programme ranging from chemical and biological sciences to specialist disciplines such as translational science, pharmacology and drug discovery. If you have graduated in 2018 or are due to graduate in 2019 and have a strong science background then you are eligible to join our programme.

Do you only accept candidates with a master's degree?

No we accept masters and bachelor graduates onto the programme and have a combination of both at any one time.

Do you only hire local candidates in each country?

 

In the US candidates need to be eligible to work, or eligible to apply for the Optional Practical Training Extension for STEM Students.

In the UK candidates need to be eligible to work.

In Sweden, candidates need to be eligible to work, or eligible to apply for a visa.

Explore our other graduates/masters programmes

Back to top